Scarica l'app Stockscreener
29.69
1.23%
0.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Alkermes Plc Borsa (ALKS) Ultime notizie
How FDA Breakthrough Therapy Status for Alixorexton Will Impact Alkermes (ALKS) Investors - simplywall.st
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug - Finviz
Alkermes plc's (NASDAQ:ALKS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - simplywall.st
Why Analysts See The Alkermes (ALKS) Story Shifting After Avadel Deal And Orexin Data - Yahoo Finance
FDA Grants Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 - Sleep Review
Is Alkermes plc (8AK) stock a top pick for value investors2026 world cup usa national team round of 16 goalkeepers set piece tactics knockout prediction expert opinion - ulpravda.ru
Is Alkermes (ALKS) Pricing Reflect Its DCF Value Gap And Recent Mixed Returns - Yahoo Finance UK
Alkermes to present at the 44th annual JP Morgan Healthcare Conference - MSN
FDA Grants Breakthrough Therapy Designation to Alixorexton for Narcolepsy Type 1 - HCP Live
Alkermes stock rises after FDA grants Breakthrough Therapy status - Investing.com
FDA grants breakthrough therapy status to Alkermes’ narcolepsy drug By Investing.com - Investing.com South Africa
Alkermes Gains FDA Breakthrough Status for Narcolepsy Drug - TipRanks
Alkermes plc Granted Breakthrough Therapy Designation for Alixorexton - TradingView — Track All Markets
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1 - Business Wire
Alkermes Plc (ALKS) Stock Analysis: Unveiling A 55% Upside Potential For Investors - DirectorsTalk Interviews
Alkermes to Host Conference Call to Discuss Financial Results for Quarter Ended June 30, 2013 - AOL.com
Insider Sell: Craig Hopkinson Sells 4,000 Shares of Alkermes PLC (ALKS) - GuruFocus
Alkermes (NASDAQ:ALKS) EVP Sells $112,000.00 in Stock - MarketBeat
J.P. Morgan Healthcare Conference - marketscreener.com
Alkermes stock rises after FDA grants Breakthrough Therapy status By Investing.com - Investing.com UK
Levels Update: Will Alkermes plc 8AK stock outperform global peersChart Signals & Short-Term Trading Alerts - moha.gov.vn
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $27.04 Million in Alkermes plc $ALKS - MarketBeat
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Centessa narcolepsy data not superior to Alkermes, says Stifel - MSN
Trading the Move, Not the Narrative: (ALKS) Edition - Stock Traders Daily
Alkermes plc $ALKS Shares Sold by Rice Hall James & Associates LLC - MarketBeat
Pacer Advisors Inc. Sells 98,825 Shares of Alkermes plc $ALKS - MarketBeat
About the Alkermes Inspiration Grants® Program - CSRwire
Alkermes plc (ALKS) Stock Price History & Data - Traders Union
Why Analysts are Rating Alkermes (ALKS) a Buy - Finviz
Why analysts are rating Alkermes (ALKS) a buy - MSN
15 Most Promising Mid-Cap Healthcare Stocks Under $50 - Insider Monkey
Alkermes plc (NASDAQ:ALKS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Alkermes plc stock positioned for digital transformation2025 Market Outlook & Weekly Breakout Watchlists - Улправда
Will Alkermes plc stock split attract more investors2025 Earnings Impact & Proven Capital Preservation Tips - Улправда
Will Alkermes plc stock benefit from commodity pricesTrade Analysis Summary & Growth Focused Stock Pick Reports - Улправда
Why global investors buy Alkermes plc (8AK) stockEarnings Recap Report & Reliable Volume Spike Alerts - Bölüm Sonu Canavarı
ALKS (Alkermes) Other Current Payables : $0 Mil (As of Sep. 2025) - GuruFocus
Will Alkermes plc (8AK) stock test record highs in 20252025 Performance Recap & Low Risk Growth Stock Ideas - DonanımHaber
Can Alkermes plc stock continue upward trendPortfolio Gains Summary & Comprehensive Market Scan Reports - DonanımHaber
Bear Alert: Will Alkermes plc stock split attract more investorsOil Prices & Technical Pattern Alert System - ulpravda.ru
Behavioral Patterns of ALKS and Institutional Flows - Stock Traders Daily
Is Alkermes plc (8AK) stock a momentum leaderTrade Risk Assessment & Real-Time Stock Entry Alerts - Улправда
How Alkermes plc (8AK) stock reacts to monetary easingBear Alert & Free Reliable Trade Execution Plans - Улправда
Alkermes (STU:8AK) OCF Margin % : 25.79% (As of Sep. 2025) - GuruFocus
BlackRock increases stake in Alkermes to 17.04% - Investing.com
REGBlackRock GroupSAR 6ALKERMES PLC - TradingView — Track All Markets
Frazier Life Sciences Management L.P. Boosts Stock Position in Alkermes plc $ALKS - MarketBeat
EcoR1 Capital LLC Makes New Investment in Alkermes plc $ALKS - MarketBeat
Retail Surge: Why global investors buy Alkermes plc 8AK stockCEO Change & Expert Curated Trade Ideas - moha.gov.vn
History Review: Will Alkermes plc 8AK stock test record highs in 2025Watch List & High Conviction Investment Ideas - moha.gov.vn
BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com South Africa
BlackRock increases stake in Alkermes to 17% - Investing.com
1.60%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):